Allevi by 3D Systems

Allevi by 3D Systems

Allevi by 3D Systems, with the slogan "Versatile and easy-to-use 3D bioprinters and bioinks. Bring your work to life," is a leading player in the biotechnology industry. Established in 2014, the company's mission is to simplify the design and engineering of 3D tissues by providing cutting-edge tools for researchers. Their desktop 3D bioprinter, renowned for its versatility, power, and user-friendliness, has gained widespread adoption, serving hundreds of labs globally and positioning the company as a pioneer in the biofabrication revolution.

The last investment in Allevi amounted to $1.00M, secured through an Initial Coin Offering investment on 01 November 2019. Notably, this round of funding was backed by The Provco Group.

Allevi's products, including 3D bioprinters, software, and bioinks, have empowered leading researchers worldwide to tackle humanity's most pressing challenges, such as curing diseases, testing novel drugs, and addressing organ shortages. The company is fueled by its commitment to supporting a community of users engaged in groundbreaking research with life-changing implications, embodying its belief in the potential for transformative contributions to the field of medicine. Allevi's innovative approach and significant impact make it a compelling contender in the biotechnology landscape.